Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)

Autor: Dana S Hardin

Publikováno v: Biologics: Targets & Therapy, Vol 2008, Iss Issue 4, Pp 655-661 (2008)

Dana S HardinOhio State University and Columbus Children’s Hospital, Columbus, Ohio, USAAbstract: Somatotropin (growth hormone, GH) of recombinant DNA origin has provided a readily available and safe drug that has greatly improved management of chi

Externí odkaz: https://doaj.org/article/1758e43d49e74764a952c0fea69fc65b

Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes

Autor: Honghua H. Jiang, Lois Jovanovič, Dana S. Hardin, Anne L. Peters

Publikováno v: Aging Clinical and Experimental Research

Background and Aims Few studies have evaluated long-term durability of glycemic control in older patients. The aim of this study was to compare durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25; 75 % insulin lispro prota

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffac67721ec995c107931a5533d7bb5
https://doi.org/10.1007/s40520-013-0140-8

Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials

Autor: Kathleen Solotkin, Richard B. Warren, Mamitaro Ohtsuki, Dana S. Hardin, Kristian Reich, Richard G. Langley, Jean-Frederic Colombel, Nayan Acharya, Ricardo Romiti, Hervé Bachelez, Craig L. Leonardi, Wen Xu

Publikováno v: Reich, K, Leonardi, C, Langley, R G, Warren, R B, Bachelez, H, Romiti, R, Ohtsuki, M, Xu, W, Acharya, N, Solotkin, K, Colombel, J-F & Hardin, D S 2017, ' Inflammatory bowel disease among patients with psoriasis treated with ixekizumab : A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials ', Journal of the American Academy of Dermatology, vol. 76, no. 3, pp. 441-448.e2 . https://doi.org/10.1016/j.jaad.2016.10.027

BACKGROUND: Inflammatory bowel disease (IBD) occurs more frequently in patients with psoriasis. The 2 diseases have significant genetic overlap, but the pathogenesis underlying their co-occurrence is unknown.OBJECTIVE: We sought to report adjudicated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b9abba7a96e6d5a3aa48ec3b9a5f74
https://pubmed.ncbi.nlm.nih.gov/28552300

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth

Autor: Amanda Zadzilka, Elizabeth Sheeran, Denise L. Jacobson, William A. Meyer, Jack Moye, Dana S. Hardin, Grace M. Aldrovandi, Kathleen Mulligan, Jane C. Lindsey, Peggy R. Borum

Publikováno v: AIDS. 23:661-672

To compare the distribution of lipid and glucose abnormalities and altered fat distribution among vertically HIV-infected patients and controls.Cross-sectional multicenter study on HIV-infected (HIV-positive) patients, 7-24 years of age, stratified b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907647434cf1fea90aa48bc124461820
https://doi.org/10.1097/qad.0b013e3283269dfb

Twenty Years of Recombinant Human Growth Hormone in Children: Relevance to Pediatric Care Providers

Autor: Stephen F. Kemp, David B. Allen, Dana S. Hardin

Publikováno v: Clinical Pediatrics. 46:279-286

Recombinant human growth hormone has revolutionized the management of children and adolescents with growth hormone deficiency and other growth disorders, but clinical and ethical controversies remain regarding diagnostic approach, optimal recombinant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a81dec3be8479a20a6e8c3dbdae8a5
https://doi.org/10.1177/0009922806293924